UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that the Centers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback